期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
TMEM100调控Notch信号对胃癌细胞增殖、迁移、侵袭与凋亡影响的实验研究
1
作者 安红贤 张艳敏 +2 位作者 卢頔 李晓娜 高艳红 《临床肿瘤学杂志》 CAS 2024年第6期526-531,共6页
目的探讨TMEM100对胃癌细胞增殖、迁移、侵袭与凋亡的影响及其可能分子机制。方法通过GEPIA数据库分析胃癌组织中TMEM100表达,实时荧光定量PCR(qPCR)检测胃癌细胞株中TMEM100表达。将胃癌SGC-7901细胞分为对照组(空载体组)、TMEM100过表... 目的探讨TMEM100对胃癌细胞增殖、迁移、侵袭与凋亡的影响及其可能分子机制。方法通过GEPIA数据库分析胃癌组织中TMEM100表达,实时荧光定量PCR(qPCR)检测胃癌细胞株中TMEM100表达。将胃癌SGC-7901细胞分为对照组(空载体组)、TMEM100过表达(转染过表达载体pcDNA3.0-HA-TMEM100)组、TMEM100过表达+Notch1激动剂(VPA-d4)组。MTT、划痕实验、Transwell小室和流式细胞术分别检测细胞增殖、迁移、侵袭和凋亡情况。结果TCGA数据显示,与正常组织比较,胃癌组织中的TMEM100表达显著降低,差异具有统计学意义(P<0.05);GES-1细胞中TMEM100表达量为1.000±0.103,均高于胃癌AGS细胞(0.693±0.091)、MKN-45细胞(0.567±0.079)、MGC80-3细胞(0.491±0.094)和SGC-7901细胞(0.415±0.0.84),差异有统计学意义(P<0.05)。与空载体组(1.000±0.184)比较,TMEM100过表达组细胞TMEM100蛋白(2.648±0.249)和mRNA(3.462±0.328)表达均升高(P<0.05);TMEM100过表达组细胞Notch1蛋白(0.417±0.103)和mRNA(0.424±0.091)表达均降低(P<0.05)。与空载体组比较,TMEM100过表达组细胞增殖活性显著降低(P<0.05);与TMEM100过表达组比较,TMEM100过表达+VPA-d4组细胞增殖活性明显升高(P<0.05)。划痕实验显示,空载体组细胞划痕愈合率为(80.3±12.3)%,高于TMEM100过表达组的(35.1±7.38)%;而TMEM100过表达+VPA-d4组细胞划痕愈合率为(79.2±12.6)%,低于TMEM100过表达组(P<0.05)。Transwell小室实验结果显示,空载体组穿膜细胞数为233±30个,高于TMEM100过表达组的72±19个,差异有统计学意义(P<0.05);与TMEM100过表达组比较,TMEM100过表达+VPA-d4组穿膜细胞数增加至257±35个,差异有统计学意义(P<0.05)。空载体组细胞凋亡率为(3.6±0.3)%,TMEM100过表达组细胞凋亡率为(19.6±1.6)%,两组差异有统计学意义(P<0.05);与TMEM100过表达组比较,TMEM100过表达+VPA-d4组细胞凋亡率降至(4.0±0.4)%,差异有统计学意义(P<0.05)。结论TMEM100在胃癌组织和细胞中表达降低,且可能通过抑制Notch1表达在胃癌中发挥抑癌作用。 展开更多
关键词 胃癌 tmem100 增殖 迁移 侵袭 凋亡
暂未订购
Regulation of TMEM100 expression by epigenetic modification,effects on proliferation and invasion of esophageal squamous carcinoma
2
作者 Yue-Feng Xu Yan Dang +5 位作者 Wei-Bo Kong Han-Lin Wang Xiu Chen Long Yao Yuan Zhao Ren-Quan Zhang 《World Journal of Clinical Oncology》 2024年第4期554-565,共12页
BACKGROUND Esophageal squamous cell carcinoma(ESCC)is a prevalent malignancy with a high morbidity and mortality rate.TMEM100 has been shown to be suppressor gene in a variety of tumors,but there are no reports on the... BACKGROUND Esophageal squamous cell carcinoma(ESCC)is a prevalent malignancy with a high morbidity and mortality rate.TMEM100 has been shown to be suppressor gene in a variety of tumors,but there are no reports on the role of TMEM100 in esophageal cancer(EC).AIM To investigate epigenetic regulation of TMEM100 expression in ESCC and the effect of TMEM100 on ESCC proliferation and invasion.METHODS Firstly,we found the expression of TMEM100 in EC through The Cancer Genome Atlas database.The correlation between TMEM100 gene expression and the survival of patients with EC was further confirmed through Kaplan-Meier analysis.We then added the demethylating agent 5-AZA to ESCC cell lines to explore the regulation of TMEM100 expression by epigenetic modification.To observe the effect of TMEM100 expression on tumor proliferation and invasion by overexpressing TMEM100.Finally,we performed gene set enrichment analysis using the Kyoto Encyclopaedia of Genes and Genomes Orthology-Based Annotation System database to look for pathways that might be affected by TMEM100 and verified the effect of TMEM100 expression on the mitogen-activated protein kinases(MAPK)pathway.RESULTS In the present study,by bioinformatic analysis we found that TMEM100 was lowly expressed in EC patients compared to normal subjects.Kaplan-meier survival analysis showed that low expression of TMEM100 was associated with poor prognosis in patients with EC.Then,we found that the demethylating agent 5-AZA resulted in increased expression of TMEM100 in ESCC cells[quantitative real-time PCR(qRT-PCR)and western blotting].Subsequently,we confirmed that overexpression of TMEM100 leads to its increased expression in ESCC cells(qRT-PCR and western blotting).Overexpression of TMEM100 also inhibited proliferation,invasion and migration of ESCC cells(cell counting kit-8 and clone formation assays).Next,by enrichment analysis,we found that the gene set was significantly enriched in the MAPK signaling pathway.The involvement of TMEM100 in the regulation of MAPK signaling pathway in ESCC cell was subsequently verified by western blotting.CONCLUSION TMEM100 is a suppressor gene in ESCC,and its low expression may lead to aberrant activation of the MAPK pathway.Promoter methylation may play a key role in regulating TMEM100 expression. 展开更多
关键词 Esophageal squamous cell carcinoma tmem100 INVASION Mitogen-activated protein kinases pathway EPIGENETIC
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部